Synonyms: AN3365 | BRII-658 | GSK2251052
Compound class:
Synthetic organic
Comment: Epetraborole (GSK2251052) is an aminomethylbenzoxaborole antibacterial compound that is an inhibitor of bacterial leucyl-tRNA synthetase (LeuRS) [2]. It is being developed for the treatment of non-tuberculous mycobacterial pulmonary disease (NTM-PD).
|
|
References |
1. Ganapathy US, Gengenbacher M, Dick T. (2021)
Epetraborole Is Active against Mycobacterium abscessus. Antimicrob Agents Chemother, 65 (10): e0115621. [PMID:34280020] |
2. Hernandez V, Crépin T, Palencia A, Cusack S, Akama T, Baker SJ, Bu W, Feng L, Freund YR, Liu L et al.. (2013)
Discovery of a novel class of boron-based antibacterials with activity against gram-negative bacteria. Antimicrob Agents Chemother, 57 (3): 1394-403. [PMID:23295920] |
3. O'Dwyer K, Spivak AT, Ingraham K, Min S, Holmes DJ, Jakielaszek C, Rittenhouse S, Kwan AL, Livi GP, Sathe G et al.. (2015)
Bacterial resistance to leucyl-tRNA synthetase inhibitor GSK2251052 develops during treatment of complicated urinary tract infections. Antimicrob Agents Chemother, 59 (1): 289-98. [PMID:25348524] |